130 related articles for article (PubMed ID: 38127812)
1. Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.
Wiesen B; Atwell M; Leavitt C; Clark N; Kessler E; Lam E; Flaig T; Kukreja J; Kim S; Maroni P; Cost NG
JCO Oncol Pract; 2024 Mar; 20(3):361-369. PubMed ID: 38127812
[TBL] [Abstract][Full Text] [Related]
2. Road map for improvement: Point prevalence audit and survey of central venous access devices in paediatric acute care.
Ullman AJ; Cooke M; Kleidon T; Rickard CM
J Paediatr Child Health; 2017 Feb; 53(2):123-130. PubMed ID: 27709723
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-Based Chemotherapy for Testicular Germ Cell Tumors: Complication Rates of Peripheral versus Central Venous Administration.
Worst T; Sautter L; John A; Weiss C; Häcker A; Heinzelbecker J
Urol Int; 2016; 96(2):177-82. PubMed ID: 26681435
[TBL] [Abstract][Full Text] [Related]
4. Central venous access device-related infections in patients with haemophilia.
Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
[TBL] [Abstract][Full Text] [Related]
5. The Effectiveness of Pediatric Central Venous Access Device Surveillance and Rounding Team: A Single-Center Study.
Hanaki S; Katayama S; Nakada S
Cureus; 2024 Apr; 16(4):e57855. PubMed ID: 38721214
[TBL] [Abstract][Full Text] [Related]
6. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physicians.
LeVasseur N; Stober C; Daigle K; Robinson A; McDiarmid S; Mazzarello S; Hutton B; Joy A; Fergusson D; Hilton J; McInnes M; Clemons M
Curr Oncol; 2018 Aug; 25(4):e298-e304. PubMed ID: 30111975
[TBL] [Abstract][Full Text] [Related]
7. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
[TBL] [Abstract][Full Text] [Related]
8. Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals.
Buckley B; Dreyfus J; Prasad M; Gayle J; Kendter J; Hall E
Haemophilia; 2018 May; 24(3):e93-e102. PubMed ID: 29577531
[TBL] [Abstract][Full Text] [Related]
9. Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
van den Bosch CH; van der Bruggen JT; Frakking FNJ; Terwisscha van Scheltinga CEJ; van de Ven CP; van Grotel M; Wellens LM; Loeffen YGT; Fiocco M; Wijnen MHWA
J Pediatr Surg; 2019 Sep; 54(9):1894-1900. PubMed ID: 30415957
[TBL] [Abstract][Full Text] [Related]
10. Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries.
Nestler T; Huber J; Laury AM; Isbarn H; Heidenreich A; Schmelz HU; Ruf CG
World J Urol; 2018 Jun; 36(6):913-920. PubMed ID: 29417289
[TBL] [Abstract][Full Text] [Related]
11. Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.
Lim MY; Al-Kali A; Ashrani AA; Begna KH; Elliott MA; Hogan WJ; Hook CC; Kaufmann SH; Letendre L; Litzow MR; Patnaik MS; Pardanani A; Tefferi A; Wolanskyj AP; Grill DE; Pruthi RK
Leuk Lymphoma; 2013 Jun; 54(6):1263-7. PubMed ID: 23088670
[TBL] [Abstract][Full Text] [Related]
12. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer.
Lapeyre-Prost A; Hug de Larauze M; Chibaudel B; Garcia ML; Guering-Meyer V; Bouché O; Boucher E; Ychou M; Dauba J; Obled S; Lièvre A; Malka D; Faroux R; Bonnet I; Taieb J; André T;
Clin Colorectal Cancer; 2016 Sep; 15(3):250-6. PubMed ID: 26752558
[TBL] [Abstract][Full Text] [Related]
14. Pediatric central venous access devices: practice, performance, and costs.
Ullman AJ; Gibson V; Takashima MD; Kleidon TM; Schults J; Saiyed M; Cattanach P; Paterson R; Cooke M; Rickard CM; Byrnes J; Chopra V
Pediatr Res; 2022 Nov; 92(5):1381-1390. PubMed ID: 35136199
[TBL] [Abstract][Full Text] [Related]
15. Surveillance methods for central venous access device-associated infections in Canadian pediatric hospitals.
Langley JM; LaRoche L; Hanakowski M
Can J Infect Control; 1995; 10(3):80-2. PubMed ID: 8555515
[TBL] [Abstract][Full Text] [Related]
16. Central venous access devices in haemophilia.
Valentino LA; Ewenstein B; Navickis RJ; Wilkes MM
Haemophilia; 2004 Mar; 10(2):134-46. PubMed ID: 14962202
[TBL] [Abstract][Full Text] [Related]
17. Inherent and modifiable risk factors for peripheral venous catheter failure during cancer treatment: a prospective cohort study.
Larsen EN; Marsh N; O'Brien C; Monteagle E; Friese C; Rickard CM
Support Care Cancer; 2021 Mar; 29(3):1487-1496. PubMed ID: 32710173
[TBL] [Abstract][Full Text] [Related]
18. A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
Fankhauser CD; Tran B; Pedregal M; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Del Muro XG; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL; Sweeney CJ; Connors JM
Eur Urol Focus; 2021 Sep; 7(5):1130-1136. PubMed ID: 33032968
[TBL] [Abstract][Full Text] [Related]
19. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
[TBL] [Abstract][Full Text] [Related]
20. Proximal humerus intraosseous infusion: a preferred emergency venous access.
Paxton JH; Knuth TE; Klausner HA
J Trauma; 2009 Sep; 67(3):606-11. PubMed ID: 19741408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
